Literature DB >> 2229651

Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis.

H Mukai1, T Noguchi, K Kamimura, K Nishioka, S Nishiyama.   

Abstract

Serum lactate dehydrogenase activity (LDH) was elevated in most cases with the severe type of atopic dermatitis (AD). We examined whether LDH correlated specifically with the clinical courses and the severity of AD skin eruptions. Blood eosinophil numbers (Eo), LDH and its isoenzymes, and serum IgE (IgE) levels in eighty patients with AD were measured before and after treatment. In improved groups, Eo and LDH decreased or returned to normal values after treatment. In contrast, both levels increased in patients who worsened after treatment. Thus changes in Eo and LDH correlated well with the clinical picture. However, IgE levels did not correlate with the clinical condition. High LDH levels were detected in the severe type of AD more frequently than in the mild type. A large majority of patients with elevated LDH (higher than 300 IU/l) before treatment had more severe skin eruptions. When the LDH before treatment was within normal limits, the LDH levels in improved patients showed a further decrease. Eo, LDH and IgE were correlated closely with the clinical scores of AD, and the relationship between LDH and clinical score was the highest. Elevations of LDH5 and LDH4 among the LDH isoenzymes were more prominent in the severe type of AD than in the mild type. We concluded that LDH was useful as a marker for evaluating the disease condition and severity of skin eruption of AD.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229651     DOI: 10.1111/j.1346-8138.1990.tb01679.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  6 in total

1.  Restoration of peripheral blood T cell repertoire complexity during remission in advanced cutaneous T cell lymphoma.

Authors:  Kei-ichi Yamanaka; Robert C Fuhlbrigge; Hitoshi Mizutani; Thomas S Kupper
Journal:  Arch Dermatol Res       Date:  2010-01-29       Impact factor: 3.017

Review 2.  The Nax (SCN7A) channel: an atypical regulator of tissue homeostasis and disease.

Authors:  David Dolivo; Adrian Rodrigues; Lauren Sun; Yingxing Li; Chun Hou; Robert Galiano; Seok Jong Hong; Thomas Mustoe
Journal:  Cell Mol Life Sci       Date:  2021-06-08       Impact factor: 9.261

3.  Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS).

Authors:  A Wollenberg; L A Beck; A Blauvelt; E L Simpson; Z Chen; Q Chen; B Shumel; F A Khokhar; T Hultsch; E Rizova; A B Rossi; N M H Graham; G Pirozzi; Y Lu; M Ardeleanu
Journal:  Br J Dermatol       Date:  2019-12-01       Impact factor: 9.302

4.  Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.

Authors:  Amy S Paller; Andreas Wollenberg; Elaine Siegfried; Diamant Thaçi; Michael J Cork; Peter D Arkwright; Melinda Gooderham; Xian Sun; John T O'Malley; Faisal A Khokhar; Jignesh Vakil; Ashish Bansal; Karli Rosner; Brad Shumel; Noah A Levit
Journal:  Paediatr Drugs       Date:  2021-08-31       Impact factor: 3.022

5.  Serum mucosa-associated epithelial chemokine in atopic dermatitis: a specific marker for severity.

Authors:  M H M Ezzat; K Y Shaheen
Journal:  Indian J Dermatol       Date:  2009-07       Impact factor: 1.494

6.  Role of Eosinophil Relative Count and Neutrophil-to-Lymphocyte Ratio in the Assessment of Severity of Atopic Dermatitis.

Authors:  Sanae Inokuchi-Sakata; Yozo Ishiuji; Michie Katsuta; Budiman Kharma; Ken-Ichi Yasuda; Mitsutoshi Tominaga; Kenji Takamori; Yoshimasa Nobeyama; Akihiko Asahina
Journal:  Acta Derm Venereol       Date:  2021-07-07       Impact factor: 3.875

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.